Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0002 Transporter Info
Gene Name ABCC2
Transporter Name Multidrug resistance-associated protein 2
Gene ID
1244
UniProt ID
Q92887
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Cyclosporine

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclosporine inhibits the transportation of Calcein AM by ABCC2 (IC50 = 10 microM) [1]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 2

 Cyclosporine inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 4.7 microM) [2]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

  DT Modulation 3

 Cyclosporine inhibits the transportation of Monoglucuronosyl bilirubin by ABCC2 (Ki = 21 microM) [3]

Affected Drug/Substrate

 Monoglucuronosyl bilirubin Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP2

  DT Modulation 4

 Cyclosporine inhibits the transportation of Vinblastine by ABCC2 (Ki = 8.11 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Vinblastine

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vinblastine inhibits the transportation of Calcein AM by ABCC2 (IC50 = 21 microM) [7]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin-Darby Canine Kidney (MDCK) cells-MRP2

  DT Modulation 2

 Vinblastine inhibits the activity of ABCC2 [9] , [10]

  Indomethacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indomethacin inhibits the transportation of Methotrexate by ABCC2 (IC50 = 0.06 microM) [8]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP2

  Cisplatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cisplatin induces the activity of ABCC2 [11]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  Dexamethasone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dexamethasone induces the activity of ABCC2 [12]

  Simvastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Simvastatin inhibits the transportation of Calcein AM by ABCC2 (IC50 = 25 +/- 2 microM) [7]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin-Darby Canine Kidney (MDCK) cells-MRP2

  Ketoprofen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoprofen inhibits the transportation of Methotrexate by ABCC2 (IC50 = 1.4 microM) [8]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP2

  Daunorubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Daunorubicin inhibits the transportation of Vinblastine by ABCC2 (Ki = 49.4 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Etoposide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etoposide inhibits the transportation of Vinblastine by ABCC2 (Ki = 756 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Reserpine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Reserpine inhibits the transportation of Vinblastine by ABCC2 (Ki = 295 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Vincristine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vincristine inhibits the transportation of Vinblastine by ABCC2 (Ki = 802 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Delavirdine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Delavirdine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 [15]

Affected Drug/Substrate

 5-Chloromethylfluorescein diacetate Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Efavirenz

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Efavirenz inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 [15]

Affected Drug/Substrate

 5-Chloromethylfluorescein diacetate Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Emtricitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Emtricitabine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 [15]

Affected Drug/Substrate

 5-Chloromethylfluorescein diacetate Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Glutathione

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glutathione inhibits the transportation of Dinitrophenyl-glutathione by ABCC2 [16]

Affected Drug/Substrate

 Dinitrophenyl-glutathione Modulation Type Inhibition

Cell System

 Madin-Darby Canine Kidney (MDCK) cells-MRP2

  Quercetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin induces the activity of ABCC2 [17]

Cell System

 Human enterocyte-like 2 cell (Caco-2)-MRP2

  Rifampicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampicin induces the activity of ABCC2 [18] , [19] , [20] , [21]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  Chenodeoxycholic acid

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chenodiol induces the activity of ABCC2 [22]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  DT Modulation 2

 Chenodeoxycholic acid induces the activity of ABCC2 [22] , [32] , [33]

  Clotrimazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clotrimazole induces the activity of ABCC2 [19]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  Phenobarbital

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenobarbital induces the activity of ABCC2 [23]

Cell System

 Hepatocyte-MRP2

  Belinostat

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Belinostat inhibits the activity of ABCC2 [24]

Cell System

 Non-small cell lung cancer (NSCLC) cell lines

  Decitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Decitabine increases the expression of ABCC2 [27]

  Citalopram

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Citalopram increases the expression of ABCC2 [28]

  Atorvastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atorvastatin inhibits the activity of ABCC2 [7]

  Lovastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lovastatin inhibits the activity of ABCC2 [7]

  Metformin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Metformin increases the expression of ABCC2 [29]

  Calcitriol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Calcitriol increases the expression of ABCC2 [30]

  Carbamazepine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Carbamazepine increases the expression of ABCC2 [31]

  Cimetidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cimetidine inhibits the activity of ABCC2 [5]

  Etodolac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etodolac inhibits the activity of ABCC2 [8]

  Vancomycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vancomycin inhibits the activity of ABCC2 [34]

  Atazanavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atazanavir inhibits the activity of ABCC2 [35]

  Darunavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Darunavir inhibits the activity of ABCC2 [35]

  Tipranavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tipranavir inhibits the activity of ABCC2 [35]

  Micafungin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Micafungin inhibits the activity of ABCC2 [36]

  Itraconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Itraconazole inhibits the activity of ABCC2 [37]

  Troleandomycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Troleandomycin induces the activity of ABCC2 [38]

  Triamcinolone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Triamcinolone induces the activity of ABCC2 [12]

  Hydrocortisone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hydrocortisone induces the activity of ABCC2 [12]

Drug Marketed but not Approved by US FDA

  Ginkgolide A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ginkgolide A increases the expression of ABCC2 [26]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

Drug in Phase 3 Trial

  Curcumin

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Curcumin inhibits the transportation of Ethacrynic acid glutathione by ABCC2 (IC50 = 5 microM) [1]

Affected Drug/Substrate

 Ethacrynic acid glutathione Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP2

  DT Modulation 2

 Curcumin inhibits the activity of ABCC2 (IC50 = 5 microM) [1]

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 3

 Curcumin inhibits the activity of ABCC2 [1]

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP2

  Resveratrol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Resveratrol increases the expression of ABCC2 [40]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Wistar rats

Drug in Phase 1 Trial

  Trichostatin A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Trichostatin A inhibits the expression of ABCC2 [41]

  Rubitecan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rubitecan increases the expression of ABCC2 [43]

Drug in Preclinical Test

  Myricetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Myricetin inhibits the activity of ABCC2 [44]

Discontinued Drug

  MK-571

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 MK-571 inhibits the transportation of Ethacrynic acid glutathione by ABCC2 (IC50 = 4 microM) [5]

Affected Drug/Substrate

 Ethacrynic acid glutathione Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP2

  DT Modulation 2

 MK-571 inhibits the transportation of Irinotecan by ABCC2 (IC50 = 50 microM) [6]

Affected Drug/Substrate

 Irinotecan Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-MRP2

  DT Modulation 3

 MK-571 inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 13.1 microM) [2]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

  DT Modulation 4

 MK-571 inhibits the transportation of Vinblastine by ABCC2 (Ki = 26.4 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Valspodar

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valspodar inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 28.9 microM) [2]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

  DT Modulation 2

 Valspodar inhibits the transportation of Vincristine by ABCC2 [2]

Affected Drug/Substrate

 Vincristine Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

Investigative Drug

  Hyperforin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hyperforin induces the activity of ABCC2 [22]

Cell System

 Hepatocyte-MRP2

Natural Product

  Pyrethroids

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pyrethroids inhibits the transportation of Probenecid by ABCC2 (IC50 = 48.2 microM) [13]

Affected Drug/Substrate

 Probenecid Modulation Type Inhibition

Cell System

 Human hepatoma HuH-7 cells-MRP2

  Tetramethrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetramethrin inhibits the transportation of Probenecid by ABCC2 (IC50 = 65.5 microM) [13]

Affected Drug/Substrate

 Probenecid Modulation Type Inhibition

Cell System

 Human hepatoma HuH-7 cells-MRP2

  Cigarette smoke condensate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cigarette smoke condensate inhibits the transportation of Rhodamine 123 by ABCC2 (IC50 = 197.4 microM) [14]

Affected Drug/Substrate

 Rhodamine 123 Modulation Type Inhibition

Cell System

 Human hepatoma HepaRG cells-MRP2

  Chinese herb Jianpijiedu

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chinese herb Jianpijiedu induces the activity of ABCC2 [25]

Cell System

 Rat breast carcinoma cell (Walker-256)-MRP2

  Ginkgolide B

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ginkgolide B increases the expression of ABCC2 [26]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Robinetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Robinetin inhibits the activity of ABCC2 [44]

  6-bromoindirubin-3'-oxime

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 6-bromoindirubin-3'-oxime increases the expression of ABCC2 [47]

Plant Extract

  Ginkgo biloba extract

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ginkgo biloba extract increases the expression of ABCC2 [26]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Apple polyphenol extract

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Apple polyphenol extract increases the expression of ABCC2 [46]

Environmental toxicant

  2-tert-butylhydroquinone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-tert-butylhydroquinone increases the expression of ABCC2 [39]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Sodium arsenate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenate increases the expression of ABCC2 [42]

  Demethoxycurcumin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Demethoxycurcumin inhibits the activity of ABCC2 [45]

Acute Toxic Substance

  2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine increases the expression of ABCC2 [48]

Pesticide/Insecticide

  Chlordecone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlordecone inhibits the activity of ABCC2 [49]

  Dieldrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dieldrin increases the expression of ABCC2 [49]

  Endosulfan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Endosulfan inhibits the activity of ABCC2 [49]

  Heptachlor

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Heptachlor inhibits the activity of ABCC2 [49]

Health and Environmental Toxicant

  Chlordan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlordan inhibits the activity of ABCC2 [49]
References
1 Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. Chem Res Toxicol. 2003 Dec;16(12):1642-51.
2 Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Mol Pharmacol. 1999 Dec;56(6):1219-28.
3 Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology. 1999 Aug;30(2):485-90.
4 Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa? Pharm Res. 2002 Jun;19(6):773-9.
5 Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport. Xenobiotica. 2005 Jul;35(7):737-53.
6 Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1. Drug Metab Dispos. 2002 Jul;30(7):763-70.
7 Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. Drug Metab Dispos. 2005 Apr;33(4):537-46.
8 Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther. 2007 Jan;320(1):229-35.
9 Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology. 2007 Feb;52(2):333-46.
10 Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer. 2000 Aug;83(3):366-74.
11 Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett. 2001 Mar 31;120(1-3):51-7.
12 Rapid, nongenomic stimulation of multidrug resistance protein 2 (Mrp2) activity by glucocorticoids in renal proximal tubule. J Pharmacol Exp Ther. 2011 Jul;338(1):362-71.
13 Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin. PLoS One. 2017 Jan 18;12(1):e0169480.
14 Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. Toxicology. 2016 Jul 1;363-364:58-71.
15 Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors. Drug Metab Dispos. 2007 Mar;35(3):340-4.
16 Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J. 1999 Mar 1;338 ( Pt 2):393-401.
17 Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochem Pharmacol. 2000 Mar 1;59(5):467-70.
18 The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol. 2000 Nov;157(5):1575-80.
19 Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology. 2002 Feb 28;171(2-3):137-46.
20 Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs. Mol Cell Biochem. 2010 Apr;337(1-2):133-43.
21 Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2. Biochem Pharmacol. 2005 Feb 1;69(3):415-23.
22 Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem. 2002 Jan 25;277(4):2908-15.
23 Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem Pharmacol. 2002 Jan 15;63(2):333-41.
24 Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat. Lung Cancer. 2017 Jan;103:58-65.
25 The Chinese Herb Jianpijiedu Contributes to the Regulation of OATP1B2 and ABCC2 in a Rat Model of Orthotopic Transplantation Liver Cancer Pretreated with Food Restriction and Diarrhea. Biomed Res Int. 2015;2015:752850.
26 Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res. 2009 Apr;26(4):872-82.
27 Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells. J Biol Chem. 2001 Oct 26;276(43):39990-40000.
28 Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). Gut. 2003 Feb;52(2):300-3.
29 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
30 Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J Steroid Biochem Mol Biol. 2016 Oct;163:77-87.
31 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
32 Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. Aliment Pharmacol Ther. 2007 Oct 15;26(8):1139-46.
33 Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol. 2003 Oct;39(4):480-8.
34 JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats. Toxicol Lett. 2018 Oct 1;295:195-204.
35 MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy Study. Drug Metab Dispos. 2018 May;46(5):697-703.
36 Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrob Agents Chemother. 2016 May 23;60(6):3372-9.
37 Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. Drug Metab Dispos. 2016 Mar;44(3):453-9.
38 Interactions of pharmaceuticals and other xenobiotics on key detoxification mechanisms and cytoskeleton in Poeciliopsis lucida hepatocellular carcinoma, PLHC-1 cell line. Toxicol In Vitro. 2013 Feb;27(1):111-20.
39 Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J Exp Ther Oncol. 2007;6(4):335-48.
40 Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. World J Gastroenterol. 2017 Nov 21;23(43):7678-7692.
41 Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. Eur J Biochem. 2000 Mar;267(5):1347-58.
42 Global alteration of gene expression in human keratinocytes by inorganic arsenic. Carcinogenesis. 2003 Apr;24(4):747-56.
43 Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol Pharmacol. 2004 Dec;66(6):1397-405.
44 Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol. 2005 Feb 15;69(4):699-708.
45 Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds. Biochem Pharmacol. 2005 Jun 15;69(12):1879-90.
46 Apple polyphenols modulate expression of selected genes related to toxicological defence and stress response in human colon adenoma cells. Int J Cancer. 2008 Jun 15;122(12):2647-55.
47 Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem. 2008 Aug;106(4):1855-65.
48 ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol. 2008 Oct 15;232(2):210-7.
49 Regulation of hepatic drug transporter activity and expression by organochlorine pesticides. J Biochem Mol Toxicol. 2014 Mar;28(3):119-28.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.